Navidea生物制药(NAVB)

0.0375 0.0007 1.902174%

今开:0.0368昨收:0.0368
最高:0.0375 最低:0.0368
涨停价:0.0跌停价:0.0
总市值:3753164.0

Navidea生物制药的最新讨论

兔斯基不吃面2020-05-22 20:26

$Navidea生物制药(NAVB)$ 下一个轮到ABUS生物制药哈哈哈,异曲同工查看全文

荣耀之战2020-05-22 06:41

$Navidea生物制药(NAVB)$ 盘后什么消息了?查看全文

小水大雨2019-12-31 01:40

$Navidea生物制药(NAVB)$ 未来几天, 估计持续上涨的机率比较大。 但是交易量很低的小盘股, 知适合很小的资金投机一下。 买了200股, 试试运气[干杯]查看全文

用户48783635432019-04-09 14:29

【汇众医疗】Navidea宣布重启NAV3-31的2b期临床试验,此后股价上升13%
$Navidea生物制药(NAVB)$ Navidea根据FDA的反馈,宣布重启对NAV3-31的2b期临床试验计划,评估成像剂Tc99m tilmanocept在类风湿性关节炎患者中的应用。此举促进该公司股价上升了13%。 查看全文网页链接查看全文

艾萨克的猫2018-10-23 23:00

$Navidea Biopharmaceuticals, Inc. (NAVB)$ Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today the company will pr...查看全文

1 2

Navidea生物制药的公告

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ DEF 14A - Other definitive proxy statements Filed: 2017-05-24 AccNo: 0001654954-17-005040 Size: 1 MB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 内部交易: 2017-05-22,COO and CFO,Latkin Jed ,买入,11200普通股, $0.45

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 内部交易: 2017-05-19,COO and CFO,Latkin Jed ,买入,14159普通股, $0.45

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2017-05-16 AccNo: 0001654954-17-004845 Size: 28 KBItem 8.01: Other Events 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-05-10 AccNo: 0001654954-17-004355 Size: 3 MB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-05-09 AccNo: 0001654954-17-004258 Size: 977 KB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2017-05-09 AccNo: 0001654954-17-004240 Size: 159 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ PRE 14A - Other preliminary proxy statements Filed: 2017-05-08 AccNo: 0001654954-17-004188 Size: 1 MB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2017-05-01 AccNo: 0001654954-17-003840 Size: 26 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http...

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2017-03-31 AccNo: 0001654954-17-002915 Size: 8 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48